Welcome to
On Feet Nation
Raymond Online
Jonathan Online
smithmorgan Online
Gennova Biopharmaceuticals Ltd., the Pune-based biotechnology company, working on the nation’s first mRNA-based COVID-19 vaccine, submitted the interim clinical data of the Phase I study to the Central Drugs Standard Control Organisation (CDSCO), the Government of India’s National Regulatory Authority (NRA).
Vaccine Subject Expert Committee (SEC) reviewed the interim Phase I data and found that HGCO19 was safe, tolerable, and immunogenic in the participants of the study.
https://indiaeducationdiary.in/dbt-birac-supported-nations-first-mr...
© 2024 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation